Clinical Trials: A Vital Part of Cystic Fibrosis Treatment Advancements

Clinical trials are vital part of advancing treatments for CF patients. Fundraising is the genesis for new treatments because it allows researchers to create new treatments, but clinical trials are the bridge from a breakthrough in the lab to a new medicine actually being available on the open Continue reading Clinical Trials: A Vital Part of Cystic Fibrosis Treatment Advancements

KaloBios Says Cystic Fibrosis-Related Treatment Gains Orphan-Drug Status

KaloBios Pharmaceuticals Inc. (KBIO) said the U.S. Food and Drug Administration granted orphan-drug designation for its treatment for cystic fibrosis patients with Pseudomonas aeruginosa. Continue reading KaloBios Says Cystic Fibrosis-Related Treatment Gains Orphan-Drug Status

CF Wind Sprint 37: Full Body Exercises to Do Outdoors

In this video, Jerry demonstrates how to use medicine balls – which are easily portable – to get a full-body work out while enjoying the outdoors fresh air. http://www.youtube.com/watch?v=vxK740xXLSc&feature=youtu.be
Continue reading CF Wind Sprint 37: Full Body Exercises to Do Outdoors

Teva announces FDA approval of generic TOBI in the United States

JERUSALEM–(BUSINESS WIRE)–Oct. 14, 2013– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announces today that the U.S. Food and Drug Administration has granted approval of the generic equivalent to TOBI® (Tobramycin Inhalation Solution Continue reading Teva announces FDA approval of generic TOBI in the United States

Guest Blog by Lisa Zaccaria–Being Strong Is Not Always Easy

A lot of people ask me how I keep remaining so positive and strong. My answer is simple: I am not always positive and strong. Although I would love to be, I wouldn’t be human if I was. Yes, I fight CF everyday and I try to beat the odds. Continue reading Guest Blog by Lisa Zaccaria–Being Strong Is Not Always Easy

Celtaxsys Initiates First Clinical Trial of Oral CTX-4430 Therapy in Cystic Fibrosis Patients

Pharmaceutical discovery and development company Celtaxsys, Inc. today announced it is now enrolling patients for its first trial of CTX-4430 oral treatment for lung disease in Cystic Fibrosis (CF) patients. In this study, the safety and Continue reading Celtaxsys Initiates First Clinical Trial of Oral CTX-4430 Therapy in Cystic Fibrosis Patients

Why hospitals shouldn’t make patients the hand-washing police

A video produced by the Centers for Disease Control and Prevention (CDC) is urging patients to make sure their doctors have washed their hands–but that’s the wrong way to go about it, according to an editorial in MedCity News. Continue reading Why hospitals shouldn’t make patients the hand-washing police

Take A Two Question Survey Regarding Medical Records Bank (MRB) Initiative

Imagine you can go anywhere for medical care, at any time of the day, and ensure that the people treating you know exactly how to take care of you. Imagine you can also directly help the medical researchers that are trying to help you….and Continue reading Take A Two Question Survey Regarding Medical Records Bank (MRB) Initiative

Cystic Fibrosis Foundation’s new rules are wrong

http://www.sfgate.com/opinion/openforum/article/Cystic-Fibrosis-Foundation-s-new-rules-are-wrong-4882983.php

Earlier this year, the Cystic Fibrosis Foundation made a new rule that “only one person with CF may be present at a CF Foundation-sponsored indoor event or meeting.” While intended as a safety measure, it bans from its own functions the Continue reading Cystic Fibrosis Foundation’s new rules are wrong

Why AbbVie’s Global Alliance With Galapagos Is Good News for Investors

Since becoming an independent company late last year, AbbVie has been making significant progress. AbbVie shares have been among the best performers in the health care sector this year, gaining nearly 31% year-to-date. The gains have come Continue reading Why AbbVie’s Global Alliance With Galapagos Is Good News for Investors